QS-21 structure/function studies: effect of acylation on adjuvant activity

By Liu G.   Anderson C.   Scaltreto H.   Barbon J.   Kensil C.R.  

Vaccine, Vol. 20, Iss. 21, 2002-06 ,pp. : 2808-2815

Elsevier

Access to resources Recommend Favorite

Adjuvant activity of QS-21 for experimental E. coli 018 polysaccharide vaccines

By Coughlin R.T.   Fattom A.   Chu C.   White A.C.   Winston S.  

Vaccine, Vol. 13, Iss. 1, 1995-01 ,pp. : 17-21

Elsevier

Access to resources Recommend Favorite

Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant QS-21

By Waite D.C.   Jacobson E.W.   Ennis F.A.   Edelman R.   White B.   Kammer R.   Anderson C.   Kensil C.R.  

Vaccine, Vol. 19, Iss. 28, 2001-07 ,pp. : 3957-3967

Elsevier

Access to resources Recommend Favorite

The adjuvant combination monophosphoryl lipid A and QS21 switches T cell responses induced with a soluble recombinant HIV protein from Th2 to Th1

By Moore A.   McCarthy L.   Mills K.H.G.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2517-2527

Elsevier

Access to resources Recommend Favorite

Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21

By Kashala O.   Amador R.   Valero M.V.   Moreno A.   Barbosa A.   Nickel B.   Daubenberger C.A.   Guzman F.   Pluschke G.   Patarroyo M.E.  

Vaccine, Vol. 20, Iss. 17, 2002-05 ,pp. : 2263-2277

Elsevier

Access to resources Recommend Favorite